Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Net Income

Amag Pharmaceuticals Net Income Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Amag Pharmaceuticals Net Income for the quarter ending June 06, 2020 was $-13m a -78.32% increase of 10m year over year
  • Amag Pharmaceuticals Net Income for the last 12 months ending June 06, 2020 was $-259m a -11.83% increase of 31m year over year
  • Amag Pharmaceuticals Annual Net Income for 2019 was $-468m a 85.35% decrease of -399m from 2018
  • Amag Pharmaceuticals Annual Net Income for 2018 was $-68m a -193.10% increase of 132m from 2017
  • Amag Pharmaceuticals Annual Net Income for 2017 was $-201m a 98.76% decrease of -198m from 2016
Other Income Statement Metrics:
  • Amag Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $0m a -35,031.33% decrease of -29m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Net Income Data

06/2020$-13m
03/2020$-23m
12/2019$-201m
09/2019$-24m
06/2019$-121m
03/2019$-122m
12/2018$-25m
09/2018$31m
06/2018$-20m
03/2018$-54m

Annual AMAG Net Income Data

2019$-468m
2018$-68m
2017$-201m
2016$-2m
2015$33m
2014$136m
2013$-10m
2012$-17m
2011$-77m
2010$-81m